| cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
| BC112935 | Uterus, leiomyosarcoma | .a | 1 to 5429 | 1 to 5429 | tiling clone, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 5429/5432 (99 %) | 8 diff (99.9 %id) | |
| BQ962234 | leiomyosarcoma, uterus | .a | 2 to 808 | 1 to 812 | 812/922 (88 %) | 13 diff (98.6 %id) | |||
| CA951123 | Pancreas, Purified pancreatic islet | .a | 49 to 157 | 1 to 109 | 109/122 (89 %) | 1 diff (99.2 %id) | |||
| BI036442 | nervous_tumor | .a | 69 to 439 | 374 to 6 | 372/375 (99 %) | 0 diff (100 %id) | |||
| NM_001076786.1 | .a | 69 to 9339 | 1 to 9271 | RefSeq, | 9271/9271 (100 %) | 0 diff (100 %id) | |||
| AA053856 | eye, retina | .a | 156 to 679 | 74 to 591 | 518/626 (82 %) | 16 diff (97.5 %id) | |||
| CN288971 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 336 to 885 | 1 to 550 | 550/550 (100 %) | 0 diff (100 %id) | |||
| AK125391 | brain | .a | 579 to 4108 | 1 to 3530 | available from FLJ, | 3530/3531 (99 %) | 8 diff (99.8 %id) | ||
| DA776296 | brain | .a | 580 to 1154 | 2 to 577 | capped | 576/576 (100 %) | 1 diff (99.9 %id) | ||
| BQ933529 | sciatic nerve | .a | 605 to 1509 | 24 to 935 | 912/935 (97 %) | 6 diff (99.4 %id) | |||
| R21298 | whole brain | .a | 700 to 1054 | 1 to 362 | 362/472 (76 %) | 9 diff (98.1 %id) | |||
| H15324 | whole brain | .a | 700 to 1185 | 1 to 501 | 501/509 (98 %) | 24 diff (95.3 %id) | |||
| H15325 | whole brain | .a | 700 to 1110 | 1 to 416 | 416/420 (99 %) | 11 diff (97.4 %id) | |||
| BQ272039 | Pancreas, Purified pancreatic islet | .a | 837 to 1403 | 1 to 567 | 567/567 (100 %) | 0 diff (100 %id) | |||
| CK825583 | Pancreas, Purified pancreatic islet | .a | 867 to 1408 | 1 to 542 | Submitted on the opposite strand | 542/542 (100 %) | 3 diff (99.5 %id) | ||
| AL834141 | testis | .a | 1306 to 6071 | 1 to 4767 | available from DKFZ, AAA | 4767/4767 (100 %) | 5 diff (99.9 %id) | ||
| DA886831 | .a | 1316 to 1871 | 2 to 557 | capped | 556/556 (100 %) | 1 diff (99.9 %id) | |||
| BM010898 | brain, neuroblastoma, cell line | .a | 1346 to 2235 | 1 to 905 | 905/927 (97 %) | 57 diff (93.9 %id) | |||
| TI_59379783 | .a | 1347 to 2235 | 104 to 1007 | 904/926 (97 %) | 57 diff (93.9 %id) | ||||
| AW976250 | .a | 1370 to 1868 | 1 to 499 | 499/501 (99 %) | 14 diff (97.3 %id) | ||||
| AA484980 | germinal center B cell | .a | 1437 to 1742 | 1 to 304 | 304/304 (100 %) | 4 diff (98.7 %id) | |||
| AW976188 | .a | 1585 to 2220 | 637 to 1 | Submitted on the opposite strand | 637/638 (99 %) | 9 diff (98.6 %id) | |||
| BQ271716 | Pancreas, Purified pancreatic islet | .a | 1645 to 2220 | 576 to 1 | 576/576 (100 %) | 0 diff (100 %id) | |||
| BM263943 | Pancreas, Purified pancreatic islet | .a | 1673 to 2220 | 548 to 1 | 548/548 (100 %) | 0 diff (100 %id) | |||
| BM353528 | Pancreas, Purified pancreatic islet | .a | 1686 to 2220 | 535 to 1 | 535/535 (100 %) | 1 diff (99.9 %id) | |||
| AW195525 | Kidney | .a | 1687 to 2221 | 536 to 1 | 536/536 (100 %) | 10 diff (98.2 %id) | |||
| BF114942 | Kidney | .a | 1689 to 2221 | 533 to 1 | 533/533 (100 %) | 2 diff (99.7 %id) | |||
| AA642350 | germinal center B cell | .a | 1707 to 2228 | 524 to 3 | 522/524 (99 %) | 0 diff (100 %id) | |||
| AA642342 | germinal center B cell | .a | 1713 to 2228 | 518 to 3 | 516/518 (99 %) | 0 diff (100 %id) | |||
| AW090520 | brain, tumor, 5 pooled (see description) | .a | 1741 to 2014 | 274 to 1 | 274/274 (100 %) | 0 diff (100 %id) | |||
| BX096091 | whole brain | .a | 1742 to 2228 | 494 to 8 | AAA | Submitted on the opposite strand | 487/494 (98 %) | 0 diff (100 %id) | |
| FN131050 | breast carcinoma | .a | 1743 to 1844 | 99 to 1 | Submitted on the opposite strand | 99/99 (100 %) | 4 diff (96.0 %id) | ||
| AI381640 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1758 to 2221 | 464 to 1 | 464/464 (100 %) | 0 diff (100 %id) | |||
| AA748708 | germinal center B cell | .a | 1801 to 2203 | 402 to 1 | 402/402 (100 %) | 6 diff (98.6 %id) | |||
| AA054228 | eye, retina | .a | 1805 to 2222 | 422 to 1 | 422/422 (100 %) | 7 diff (98.4 %id) | |||
| AW015318 | .a | 1811 to 2235 | 428 to 4 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 425/428 (99 %) | 0 diff (100 %id) | ||
| H15709 | whole brain | .a | 1842 to 2207 | 371 to 3 | 369/376 (98 %) | 0 diff (100 %id) | |||
| AI361625 | anaplastic oligodendroglioma, brain | .a | 1864 to 2221 | 358 to 1 | 358/358 (100 %) | 0 diff (100 %id) | |||
| AI915962 | Kidney | .a | 1866 to 2221 | 355 to 1 | 355/355 (100 %) | 1 diff (99.8 %id) | |||
| R46144 | whole brain | .a | 1877 to 2228 | 367 to 2 | 366/367 (99 %) | 0 diff (100 %id) | |||
| CN304228 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 1896 to 2602 | 1 to 707 | 707/707 (100 %) | 0 diff (100 %id) | |||
| AK123858 | brain | .a | 1939 to 4828 | 1 to 2890 | available from FLJ, | 2890/2890 (100 %) | 6 diff (99.8 %id) | ||
| DA770933 | brain | .a | 1940 to 2470 | 2 to 532 | capped | 531/531 (100 %) | 0 diff (100 %id) | ||
| DA326562 | hippocampus | .a | 2027 to 2692 | 2 to 667 | capped | 666/666 (100 %) | 1 diff (99.9 %id) | ||
| DB227692 | trachea | .a | 2103 to 2665 | 2 to 564 | capped | 563/563 (100 %) | 1 diff (99.9 %id) | ||
| DA113192 | cerebellum | .a | 2319 to 2899 | 2 to 583 | capped | 582/582 (100 %) | 2 diff (99.7 %id) | ||
| CN304227 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 2384 to 3038 | 1 to 654 | 654/654 (100 %) | 1 diff (99.9 %id) | |||
| EH314489 | .a | 2394 to 2448 | 1 to 55 | 55/55 (100 %) | 1 diff (98.2 %id) | ||||
| AK125902 | testis | .a | 2453 to 6071 | 1 to 3619 | tiling clone, available from FLJ, | 3619/3619 (100 %) | 3 diff (100.0 %id) | ||
| DB069045 | testis | .a | 2454 to 2991 | 2 to 539 | capped | 538/538 (100 %) | 0 diff (100 %id) | ||
| CD654716 | Embryonic Stem cells | .a | 2475 to 3251 | 1 to 768 | 768/798 (96 %) | 6 diff (99.3 %id) | |||
| CN304226 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 2491 to 3105 | 1 to 615 | 615/615 (100 %) | 0 diff (100 %id) | |||
| CV569523 | cornea, eye | .a | 2508 to 3116 | 1 to 609 | 609/609 (100 %) | 0 diff (100 %id) | |||
| AI903739 | breast | .a | 2574 to 2758 | 1 to 185 | 185/185 (100 %) | 0 diff (100 %id) | |||
| CV312013 | ovary | .a | 2680 to 3024 | 13 to 359 | 347/359 (96 %) | 6 diff (98.4 %id) | |||
| L44446 | .a | 2807 to 3151 | 1 to 345 | 345/345 (100 %) | 2 diff (99.5 %id) | ||||
| CA428919 | Cell Line, Chondrosarcoma | .a | 2814 to 3076 | 10 to 272 | Submitted on the opposite strand | 263/272 (96 %) | 6 diff (97.8 %id) | ||
| CV571977 | cornea, eye | .a | 2952 to 3251 | 1 to 300 | 300/300 (100 %) | 13 diff (95.7 %id) | |||
| BF816181 | colon_ins | .a | 3042 to 3615 | 583 to 11 | Submitted on the opposite strand | 573/587 (97 %) | 0 diff (100 %id) | ||
| BC013746 | Kidney, hypernephroma | .a | 3075 to 4122 | 1 to 1047 | available from MGC, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 1047/1050 (99 %) | 5 diff (99.6 %id) | |
| BG164470 | hypernephroma, cell line, Kidney | .a | 3076 to 3757 | 1 to 679 | available from MGC, | 679/927 (73 %) | 10 diff (99.0 %id) | ||
| BP234335 | coronary artery | .a | 3080 to 3661 | 1 to 581 | 581/581 (100 %) | 3 diff (99.5 %id) | |||
| AI061251 | .a | 3124 to 3554 | 431 to 1 | tiling clone, | 431/431 (100 %) | 0 diff (100 %id) | |||
| BP238641 | Liver | .a | 3274 to 3863 | 1 to 591 | 591/591 (100 %) | 7 diff (98.9 %id) | |||
| BG940938 | blood | .a | 3285 to 3695 | 1 to 411 | 411/411 (100 %) | 2 diff (99.6 %id) | |||
| BX098985 | liver and spleen | .a | 3344 to 4122 | 1 to 779 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 779/803 (97 %) | 5 diff (99.4 %id) | |
| BX643085 | .a | 3362 to 3954 | 9 to 600 | 592/600 (98 %) | 6 diff (99.0 %id) | ||||
| DN997410 | breast cancer, Mammary gland (cancer tissue) | .a | 3381 to 4014 | 8 to 641 | 634/641 (98 %) | 6 diff (99.1 %id) | |||
| CN259427 | embryonic stem cells, DMSO-treated H9 cellline | .a | 3389 to 4188 | 1 to 801 | 801/801 (100 %) | 7 diff (99.2 %id) | |||
| BG960164 | colon | .a | 3395 to 3589 | 226 to 37 | 190/226 (84 %) | 0 diff (100 %id) | |||
| T06034 | .a | 3397 to 3688 | 293 to 1 | 293/293 (100 %) | 2 diff (99.4 %id) | ||||
| DA451918 | tongue, tumor tissue | .a | 3529 to 4117 | 2 to 590 | capped | 589/589 (100 %) | 1 diff (99.9 %id) | ||
| DB325997 | brain | .a | 3556 to 4108 | 556 to 2 | 555/556 (99 %) | 0 diff (100 %id) | |||
| AI076404 | liver and spleen | .a | 3687 to 4109 | 423 to 1 | 423/423 (100 %) | 0 diff (100 %id) | |||
| AA704431 | liver and spleen | .a | 3709 to 4109 | 401 to 1 | 401/401 (100 %) | 1 diff (99.8 %id) | |||
| BQ326932 | colon_normal | .a | 3825 to 3969 | 147 to 2 | 146/147 (99 %) | 0 diff (100 %id) | |||
| CN259429 | embryonic stem cells, DMSO-treated H9 cellline | .a | 3831 to 4366 | 1 to 536 | 536/536 (100 %) | 2 diff (99.7 %id) | |||
| DA828663 | placenta | .a | 3857 to 4614 | 2 to 764 | capped | 760/825 (92 %) | 7 diff (99.2 %id) | ||
| DB330452 | .a | 4283 to 4828 | 549 to 1 | 549/549 (100 %) | 3 diff (99.5 %id) | ||||
| AA905517 | pooled | .a | 4300 to 4838 | 539 to 1 | 539/539 (100 %) | 0 diff (100 %id) | |||
| DB325730 | brain | .a | 4328 to 4822 | 504 to 7 | 498/504 (98 %) | 1 diff (99.9 %id) | |||
| AI149869 | .a | 4346 to 4841 | 496 to 1 | 496/496 (100 %) | 0 diff (100 %id) | ||||
| DB214150 | trachea | .a | 4613 to 5165 | 2 to 554 | capped | 553/553 (100 %) | 1 diff (99.9 %id) | ||
| DB091022 | testis | .a | 4623 to 5180 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
| AA810522 | germinal center B cell | .a | 4629 to 4844 | 220 to 4 | 217/220 (98 %) | 1 diff (99.6 %id) | |||
| AW364104 | colon | .a | 4642 to 4888 | 6 to 250 | 245/250 (98 %) | 6 diff (97.6 %id) | |||
| CD632282 | .a | 4648 to 5219 | 8 to 582 | 575/594 (96 %) | 15 diff (97.5 %id) | ||||
| CD632283 | .a | 4648 to 5219 | 570 to 7 | 564/577 (97 %) | 13 diff (97.8 %id) | ||||
| BI821376 | pooled brain, lung, testis | .a | 4758 to 5560 | 1 to 806 | 806/807 (99 %) | 9 diff (98.9 %id) | |||
| TI_57200525 | .a | 4758 to 5560 | 33 to 838 | 806/839 (96 %) | 15 diff (98.3 %id) | ||||
| BE243663 | leukopheresis | .a | 4843 to 5190 | 348 to 1 | 348/349 (99 %) | 0 diff (100 %id) | |||
| BF029385 | bladder, carcinoma, cell line | .a | 4886 to 5442 | 1 to 549 | 552/857 (64 %) | 26 diff (97.0 %id) | |||
| BU160226 | melanotic melanoma, skin | .a | 4946 to 5747 | 1 to 813 | 813/852 (95 %) | 14 diff (98.4 %id) | |||
| DA662304 | .a | 4997 to 5572 | 2 to 578 | capped | 577/577 (100 %) | 2 diff (99.7 %id) | |||
| BQ222001 | melanotic melanoma, skin | .a | 5055 to 5904 | 1 to 855 | 855/869 (98 %) | 11 diff (98.8 %id) | |||
| BI088976 | cervix | .a | 5064 to 5858 | 13 to 809 | 797/892 (89 %) | 15 diff (98.4 %id) | |||
| AA127281 | lung, lung carcinoma | .a | 5071 to 5284 | 1 to 216 | 216/216 (100 %) | 2 diff (99.1 %id) | |||
| BP235969 | coronary artery | .a | 5077 to 5663 | 1 to 589 | 589/589 (100 %) | 7 diff (98.9 %id) | |||
| DA222221 | brain | .a | 5087 to 5644 | 2 to 559 | capped | 558/558 (100 %) | 1 diff (99.9 %id) | ||
| BP335729 | coronary artery | .a | 5193 to 5780 | 1 to 587 | 587/587 (100 %) | 2 diff (99.7 %id) | |||
| EH333935 | .a | 5195 to 5277 | 1 to 85 | 85/85 (100 %) | 2 diff (97.7 %id) | ||||
| AA588648 | adrenal adenoma, adrenal gland | .a | 5245 to 5630 | 1 to 387 | Submitted on the opposite strand | 387/387 (100 %) | 5 diff (98.8 %id) | ||
| BX643311 | .a | 5247 to 5916 | 1 to 673 | 673/673 (100 %) | 2 diff (99.8 %id) | ||||
| CD653405 | Embryonic Stem cells | .a | 5326 to 6088 | 1 to 758 | 758/852 (88 %) | 14 diff (98.4 %id) | |||
| DB216161 | trachea | .a | 5384 to 5913 | 2 to 531 | capped | 530/530 (100 %) | 0 diff (100 %id) | ||
| BX489426 | .a | 5445 to 6042 | 1 to 598 | 598/598 (100 %) | 2 diff (99.7 %id) | ||||
| CN370402 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 5458 to 5858 | 1 to 400 | 400/400 (100 %) | 1 diff (99.8 %id) | |||
| DB373242 | placenta | .a | 5464 to 6071 | 606 to 1 | 606/613 (98 %) | 29 diff (95.3 %id) | |||
| DB339989 | testis | .a | 5515 to 6071 | 560 to 1 | 560/560 (100 %) | 3 diff (99.5 %id) | |||
| CN370404 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 5542 to 5680 | 1 to 138 | 138/138 (100 %) | 2 diff (98.6 %id) | |||
| AK055185 | tongue, tumor tissue | .a | 5546 to 8415 | 1 to 2870 | tiling clone, available from FLJ, | 2870/2870 (100 %) | 4 diff (99.9 %id) | ||
| DA435086 | tongue, tumor tissue | .a | 5547 to 6114 | 2 to 569 | capped | 568/568 (100 %) | 2 diff (99.7 %id) | ||
| DA248930 | brain | .a | 5634 to 6230 | 2 to 598 | capped | 597/597 (100 %) | 1 diff (99.9 %id) | ||
| AI075772 | liver and spleen | .a | 5642 to 6072 | 433 to 4 | 430/433 (99 %) | 0 diff (100 %id) | |||
| BG026723 | Bone, osteosarcoma, cell line | .a | 5646 to 6361 | 9 to 723 | 715/918 (77 %) | 31 diff (96.7 %id) | |||
| CN370403 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 5683 to 5971 | 19 to 310 | 292/310 (94 %) | 6 diff (98.1 %id) | |||
| AA127280. matches multiple genes | lung, lung carcinoma | .a | 5685 to 6072 | 392 to 2 | also hits gene SLC25A38 | 391/397 (98 %) | 0 diff (100 %id) | ||
| AW469421 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .a | 5726 to 6012 | 287 to 1 | 287/287 (100 %) | 0 diff (100 %id) | |||
| AA453019 | .a | 5775 to 6072 | 300 to 3 | 298/300 (99 %) | 0 diff (100 %id) | ||||
| AA764828 | germinal center B cell | .a | 5788 to 6071 | 297 to 14 | AAA | 284/284 (100 %) | 0 diff (100 %id) | ||
| DB158740 | thymus | .a | 5820 to 6416 | 2 to 598 | capped | 597/597 (100 %) | 1 diff (99.9 %id) | ||
| CB218565 | mandible, pooled | .a | 5848 to 6194 | 16 to 363 | Submitted on the opposite strand | 348/363 (95 %) | 6 diff (98.4 %id) | ||
| CB218566 | mandible, pooled | .a | 5848 to 6194 | 348 to 1 | Submitted on the opposite strand | 348/363 (95 %) | 8 diff (97.8 %id) | ||
| EL595126 | epidermis, skin | .a | 5916 to 6447 | 20 to 551 | 532/565 (94 %) | 4 diff (99.3 %id) | |||
| AL699927 | human skeletal muscle | .a | 5926 to 6582 | 1 to 657 | tiling clone, | 657/657 (100 %) | 0 diff (100 %id) | ||
| EH348107 | .a | 5972 to 6048 | 1 to 77 | 77/77 (100 %) | 0 diff (100 %id) | ||||
| DA447502 | tongue, tumor tissue | .a | 5987 to 6564 | 2 to 579 | capped | 578/578 (100 %) | 0 diff (100 %id) | ||
| CN292776 | embryonic stem cells, DMSO-treated H9 cellline | .a | 5992 to 6490 | 1 to 500 | 500/500 (100 %) | 2 diff (99.6 %id) | |||
| DB214820 | trachea | .a | 5999 to 6493 | 2 to 496 | capped | 495/495 (100 %) | 0 diff (100 %id) | ||
| DA856157 | placenta | .a | 6016 to 6587 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | ||
| AA525279 | ovary | .a | 6091 to 6366 | 1 to 276 | 276/325 (84 %) | 4 diff (98.8 %id) | |||
| DA510657 | brain | .a | 6139 to 6712 | 2 to 576 | capped | 575/575 (100 %) | 3 diff (99.5 %id) | ||
| DB161137 | thymus | .a | 6141 to 6727 | 2 to 589 | capped | 588/588 (100 %) | 1 diff (99.9 %id) | ||
| DA409250 | thalamus | .a | 6172 to 6739 | 2 to 571 | capped | 570/570 (100 %) | 4 diff (99.3 %id) | ||
| DA736736 | .a | 6202 to 7042 | 2 to 848 | capped | 847/847 (100 %) | 14 diff (98.4 %id) | |||
| DA790117 | brain | .a | 6308 to 6897 | 2 to 591 | capped | 590/590 (100 %) | 0 diff (100 %id) | ||
| BE535216 | cervix | .a | 6384 to 7064 | 1 to 669 | 669/951 (70 %) | 16 diff (98.4 %id) | |||
| U51700 | heart, normal gingiva | .a | 6390 to 6628 | 239 to 1 | 239/239 (100 %) | 2 diff (99.2 %id) | |||
| DA795333 | brain | .a | 6417 to 6983 | 2 to 569 | capped | 568/568 (100 %) | 3 diff (99.5 %id) | ||
| DA439268 | tongue, tumor tissue | .a | 6423 to 6986 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
| DA071318 | cerebellum | .a | 6425 to 6987 | 2 to 566 | capped | 565/565 (100 %) | 2 diff (99.7 %id) | ||
| AI904835 | breast | .a | 6428 to 6886 | 42 to 500 | 459/500 (91 %) | 6 diff (98.8 %id) | |||
| DA449981 | tongue, tumor tissue | .a | 6546 to 7122 | 2 to 579 | capped | 578/578 (100 %) | 2 diff (99.7 %id) | ||
| DA830682 | placenta | .a | 6546 to 7280 | 2 to 750 | capped | 749/826 (90 %) | 24 diff (97.1 %id) | ||
| BM479174 | melanotic melanoma, skin | .a | 6605 to 7562 | 1 to 963 | 963/1046 (92 %) | 30 diff (97.2 %id) | |||
| BG616094 | embryonal carcinoma, testis | .a | 6703 to 7288 | 1 to 596 | 596/817 (72 %) | 21 diff (97.5 %id) | |||
| CA397243 | eye, RPE/choroid | .a | 6707 to 7336 | 1 to 631 | 631/631 (100 %) | 2 diff (99.7 %id) | |||
| BG029448 | breast, mammary adenocarcinoma, cell line | .a | 6725 to 7274 | 88 to 636 | 549/950 (57 %) | 6 diff (99.4 %id) | |||
| DA177444 | amygdala | .a | 6800 to 7345 | 2 to 547 | capped | 546/546 (100 %) | 0 diff (100 %id) | ||
| DA833462 | placenta | .a | 6835 to 7591 | 2 to 761 | capped | 760/769 (98 %) | 9 diff (98.9 %id) | ||
| BU189561 | melanotic melanoma, skin | .a | 6915 to 7777 | 1 to 872 | 872/886 (98 %) | 16 diff (98.2 %id) | |||
| AK095528 | brain | .a | 6925 to 9335 | 1 to 2411 | tiling clone, available from FLJ, | 2411/2411 (100 %) | 2 diff (100.0 %id) | ||
| DA483429 | brain | .a | 6926 to 7814 | 2 to 887 | capped | 886/887 (99 %) | 9 diff (99.0 %id) | ||
| DA159720 | amygdala | .a | 6935 to 7487 | 2 to 554 | capped | 553/553 (100 %) | 1 diff (99.9 %id) | ||
| DA785694 | brain | .a | 6938 to 7520 | 2 to 584 | capped | 583/583 (100 %) | 1 diff (99.9 %id) | ||
| BM455727 | lymph, lymphoma, cell line | .a | 6940 to 7577 | 25 to 666 | 642/1126 (57 %) | 6 diff (99.5 %id) | |||
| DA520044 | brain | .a | 6985 to 7544 | 2 to 561 | capped | 560/560 (100 %) | 0 diff (100 %id) | ||
| DA500157 | brain | .a | 6987 to 7558 | 2 to 574 | capped | 573/573 (100 %) | 2 diff (99.7 %id) | ||
| R18974 | whole brain | .a | 7027 to 7336 | 1 to 311 | 311/400 (77 %) | 2 diff (99.5 %id) | |||
| DA999986 | breast, tumor tissue | .a | 7028 to 7573 | 2 to 548 | capped | 547/547 (100 %) | 1 diff (99.9 %id) | ||
| DA554123 | .a | 7031 to 7594 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | |||
| DA751679 | .a | 7032 to 7579 | 2 to 550 | capped | 549/549 (100 %) | 2 diff (99.7 %id) | |||
| BU170648 | eye, retinoblastoma | .a | 7059 to 7984 | 1 to 925 | 925/925 (100 %) | 9 diff (99.1 %id) | |||
| CN371457 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 7060 to 7778 | 1 to 717 | 717/717 (100 %) | 2 diff (99.8 %id) | |||
| BU154784 | melanotic melanoma, skin | .a | 7094 to 7917 | 1 to 833 | 833/904 (92 %) | 18 diff (98.1 %id) | |||
| DB257497 | uterus | .a | 7094 to 7658 | 2 to 566 | capped | 565/565 (100 %) | 1 diff (99.9 %id) | ||
| DB210473 | trachea | .a | 7233 to 7806 | 2 to 577 | capped | 576/576 (100 %) | 4 diff (99.4 %id) | ||
| BG108570 | Bone, osteosarcoma, cell line | .a | 7347 to 7774 | 1 to 425 | 425/425 (100 %) | 3 diff (99.3 %id) | |||
| DA733466 | .a | 7350 to 8067 | 2 to 724 | capped | 723/723 (100 %) | 10 diff (98.7 %id) | |||
| BF795368 | lymph, lymphoma, cell line | .a | 7367 to 7774 | 1 to 409 | 409/409 (100 %) | 1 diff (99.8 %id) | |||
| AA280094 | germinal center B cell | .a | 7368 to 7860 | 1 to 492 | 492/492 (100 %) | 1 diff (99.8 %id) | |||
| CN371456 | embryonic stem cells, DMSO-treated H9 cellline | .a | 7379 to 7626 | 1 to 248 | 248/248 (100 %) | 0 diff (100 %id) | |||
| BU195039 | melanotic melanoma, skin | .a | 7469 to 8007 | 14 to 554 | 541/944 (57 %) | 16 diff (98.4 %id) | |||
| CB159064 | Liver | .a | 7496 to 8112 | 1 to 617 | 617/617 (100 %) | 0 diff (100 %id) | |||
| BJ997868 | Wilms tumor | .a | 7529 to 8128 | 1 to 600 | 600/600 (100 %) | 0 diff (100 %id) | |||
| BM718406 | eye, fetal eye | .a | 7541 to 8198 | 1 to 658 | Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) | 658/658 (100 %) | 0 diff (100 %id) | ||
| Z44768 | brain, total brain | .a | 7645 to 7993 | 1 to 350 | 350/350 (100 %) | 2 diff (99.5 %id) | |||
| CA430087 | cell lines, Chondrosarcoma | .a | 7658 to 8415 | 776 to 19 | AAA | Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) | 758/758 (100 %) | 5 diff (99.4 %id) | |
| CA430191 | cell lines, Chondrosarcoma | .a | 7784 to 8415 | 650 to 19 | AAA | Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) | 632/632 (100 %) | 0 diff (100 %id) | |
| CD103025 | Pooled-Skin | .a | 7789 to 8444 | 1 to 665 | 665/794 (83 %) | 23 diff (97.2 %id) | |||
| BG121009 | adenocarcinoma, cell line, Liver | .a | 7863 to 8626 | 1 to 752 | 752/934 (80 %) | 26 diff (97.3 %id) | |||
| DB313335 | tongue, tumor tissue | .a | 7883 to 8415 | 533 to 1 | 533/533 (100 %) | 0 diff (100 %id) | |||
| R19330 | whole brain | .a | 7894 to 8213 | 1 to 329 | Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) | 329/359 (91 %) | 15 diff (95.9 %id) | ||
| R44859 | whole brain | .a | 8249 to 8651 | 415 to 2 | tiling clone, | 414/462 (89 %) | 0 diff (100 %id) | ||
| BM683461 | eye, fetal eye | .a | 8727 to 9332 | 620 to 15 | AAA | Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) | 606/606 (100 %) | 1 diff (99.9 %id) | |
| DB380205 | placenta | .a | 8740 to 9335 | 592 to 1 | 592/601 (98 %) | 18 diff (97.1 %id) | |||
| DB365384 | .a | 8760 to 9332 | 579 to 1 | 579/587 (98 %) | 10 diff (98.3 %id) | ||||
| DB375968 | placenta | .a | 8765 to 9335 | 571 to 1 | 571/571 (100 %) | 15 diff (97.4 %id) | |||
| DB369285 | .a | 8771 to 9335 | 560 to 1 | 560/560 (100 %) | 14 diff (97.5 %id) | ||||
| DB315025 | brain | .a | 8785 to 9335 | 552 to 1 | 552/552 (100 %) | 1 diff (99.9 %id) | |||
| DB316297 | brain | .a | 8805 to 9335 | 531 to 1 | 531/531 (100 %) | 1 diff (99.9 %id) | |||
| AA280025 | germinal center B cell | .a | 8988 to 9335 | 350 to 1 | 350/353 (99 %) | 2 diff (99.5 %id) | |||
| R44598 | whole brain | .a | 9026 to 9335 | 327 to 15 | AAA | Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) | 313/327 (95 %) | 7 diff (97.9 %id) | |
| Z40582 | brain, total brain | .a | 9055 to 9332 | 278 to 1 | 278/278 (100 %) | 0 diff (100 %id) | |||
| DW425250 | Liver | .b | 1 to 268 | 17 to 284 | tiling clone, | 268/286 (93 %) | 8 diff (97.3 %id) | ||
| AK126023 | testis | .b | 80 to 5131 | 1 to 5052 | N779S L1316* | tiling clone, available from FLJ, | 5052/5052 (100 %) | 3 diff (100.0 %id) | |
| DB082295 | testis | .b | 81 to 620 | 2 to 541 | capped | 540/540 (100 %) | 0 diff (100 %id) | ||
| DB340900 | testis | .b | 4592 to 5129 | 540 to 3 | 538/540 (99 %) | 0 diff (100 %id) | |||
| AK025577 | .c | 1 to 2415 | 1 to 2415 | N38S K522E I711L | tiling clone, available from FLJ, AAA | 2415/2415 (100 %) | 5 diff (99.8 %id) | ||
| BP228925 | brain | .c | 2107 to 2687 | 1 to 581 | tiling clone, | 581/581 (100 %) | 0 diff (100 %id) | ||
| AI922837 | adenocarcinoma, Pancreas | .c | 2141 to 2415 | 304 to 29 | AAA | 276/276 (100 %) | 10 diff (96.4 %id) | ||
| CN293793 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .c | 2411 to 2567 | 1 to 157 | 157/167 (94 %) | 1 diff (99.5 %id) | |||
| BU072517 | Pancreas, Purified pancreatic islet | .d | 1 to 448 | 1 to 448 | exact | tiling clone, | 448/448 (100 %) | 2 diff (99.6 %id) | |
| CD644699 | Embryonic Stem cells | .e | 1 to 817 | 12 to 822 | Q87T A102X F106X P110X P112X ... | tiling clone, | 811/829 (97 %) | 19 diff (97.8 %id) | |
| CD657089 | Embryonic Stem cells | .e | 1 to 771 | 12 to 777 | tiling clone, | 766/818 (93 %) | 18 diff (97.8 %id) | ||
| DA801966 | brain | .f-u | 1 to 471 | 2 to 472 | tiling clone, to resequence, capped | 471/471 (100 %) | 0 diff (100 %id) | ||
| DA189148 | amygdala | .f-u | 284 to 869 | 2 to 588 | tiling clone, capped | 587/587 (100 %) | 2 diff (99.7 %id) | ||
| CD644067 | Embryonic Stem cells | .f-u | 519 to 1314 | 12 to 798 | exact | tiling clone, | 787/817 (96 %) | 16 diff (98.1 %id) | |
| BX501133 | Liver | .f-u | 530 to 1243 | 1 to 714 | M22V | tiling clone, | 714/714 (100 %) | 3 diff (99.6 %id) | |
| DB220902 | trachea | .f-u | 576 to 1151 | 2 to 577 | exact | capped | 576/576 (100 %) | 1 diff (99.9 %id) | |
| BF542002 | hypernephroma, Kidney | .f-u | 2074 to 2774 | 1 to 707 | tiling clone, | 707/718 (98 %) | 28 diff (96.2 %id) | ||
| DA612831 | .f-u | 2085 to 2669 | 2 to 588 | capped | 587/587 (100 %) | 2 diff (99.7 %id) | |||
| BG164932 | hypernephroma, cell line, Kidney | .f-u | 2135 to 2961 | 1 to 831 | 831/871 (95 %) | 48 diff (94.5 %id) | |||
| DT220460 | brain | .f-u | 2159 to 2791 | 1 to 633 | 633/635 (99 %) | 2 diff (99.7 %id) | |||
| BE905160 | epithelioid carcinoma, Pancreas | .f-u | 2176 to 2959 | 1 to 775 | 775/794 (97 %) | 31 diff (96.1 %id) | |||
| AW606194 | head_neck | .f-u | 2186 to 2451 | 274 to 8 | 267/277 (96 %) | 0 diff (100 %id) | |||
| AI824802 | pooled germ cell tumors | .f-u | 2212 to 2555 | 345 to 1 | 345/349 (98 %) | 1 diff (99.8 %id) | |||
| BG498331 | adenocarcinoma, Prostate | .f-u | 2241 to 2899 | 1 to 656 | 656/656 (100 %) | 5 diff (99.3 %id) | |||
| CF618807 | Pooled Chondrosarcoma Tumor cells | .f-u | 2241 to 2996 | 1 to 779 | 779/904 (86 %) | 6 diff (99.4 %id) | |||
| CF618806 | Pooled Chondrosarcoma Tumor cells | .f-u | 2241 to 3029 | 1 to 795 | 795/894 (88 %) | 6 diff (99.4 %id) | |||
| CD102117 | Pooled-Skin | .f-u | 2242 to 2980 | 1 to 744 | 744/750 (99 %) | 11 diff (98.6 %id) | |||
| AW382784 | head_neck | .f-u | 2243 to 2591 | 367 to 19 | 349/367 (95 %) | 0 diff (100 %id) | |||
| BE931923 | head_neck | .f-u | 2263 to 2588 | 14 to 343 | 330/352 (93 %) | 23 diff (93.5 %id) | |||
| BY796117 | eye | .f-u | 2306 to 2880 | 1 to 575 | 575/575 (100 %) | 0 diff (100 %id) | |||
| BM459681 | leiomyosarcoma, uterus | .f-u | 2343 to 3218 | 1 to 882 | tiling clone, | 882/882 (100 %) | 15 diff (98.3 %id) | ||
| BM711453 | eye, fetal eyes | .f-u | 2399 to 2940 | 1 to 542 | 542/542 (100 %) | 1 diff (99.9 %id) | |||
| BM476067 | eye, retinoblastoma | .f-u | 2408 to 3436 | 6 to 1047 | 1042/1070 (97 %) | 6 diff (99.5 %id) | |||
| AA249363 | .f-u | 2416 to 2552 | 1 to 134 | 134/134 (100 %) | 7 diff (94.8 %id) | ||||
| BG494611 | lung, mucoepidermoid carcinoma | .f-u | 2467 to 3060 | 1 to 593 | 593/593 (100 %) | 2 diff (99.7 %id) | |||
| N78362 | multiple sclerosis lesions | .f-u | 2522 to 3077 | 1 to 563 | fully sequenced, | 563/563 (100 %) | 14 diff (97.6 %id) | ||
| CR739358 | .f-u | 2618 to 3104 | 1 to 487 | 487/487 (100 %) | 0 diff (100 %id) | ||||
| FN162049 | breast carcinoma | .f-u | 2631 to 2732 | 104 to 2 | Submitted on the opposite strand | 103/107 (96 %) | 0 diff (100 %id) | ||
| H88600 | cochlea, ear | .f-u | 2655 to 3042 | 1 to 395 | fully sequenced, | 395/395 (100 %) | 10 diff (97.5 %id) | ||
| TI_154115496 | .f-u | 2673 to 3475 | 877 to 85 | AAA | 793/943 (84 %) | 10 diff (99.0 %id) | |||
| BU194044 | melanotic melanoma, skin | .f-u | 2677 to 3472 | 1 to 795 | AAA | 795/795 (100 %) | 3 diff (99.7 %id) | ||
| AA136958 | uterus | .f-u | 2704 to 3064 | 1 to 369 | fully sequenced, | 369/369 (100 %) | 14 diff (96.3 %id) | ||
| BP423644 | small intestine | .f-u | 2739 to 3260 | 1 to 522 | Submitted on the opposite strand | 522/522 (100 %) | 0 diff (100 %id) | ||
| BF241191 | bone marrow, from acute myelogenous leukemia | .f-u | 2846 to 3369 | 1 to 519 | 519/887 (58 %) | 43 diff (95.2 %id) | |||
| CA449218 | Chondrosarcoma, Left Pubic Bone | .f-u | 2847 to 3475 | 644 to 16 | AAA | 629/629 (100 %) | 0 diff (100 %id) | ||
| AW294894 | .f-u | 2895 to 3475 | 595 to 15 | AAA | 581/581 (100 %) | 4 diff (99.4 %id) | |||
| DB326979 | brain | .f-u | 2916 to 3472 | 558 to 1 | to resequence, | 558/558 (100 %) | 1 diff (99.9 %id) | ||
| BE465417 | Kidney | .f-u | 2933 to 3475 | 542 to 1 | 542/542 (100 %) | 2 diff (99.7 %id) | |||
| AI656243 | pooled germ cell tumors | .f-u | 2939 to 3476 | 538 to 1 | 538/538 (100 %) | 4 diff (99.3 %id) | |||
| AI809614 | pooled | .f-u | 2961 to 3479 | 522 to 4 | 519/522 (99 %) | 0 diff (100 %id) | |||
| AW631327 | pooled | .f-u | 2961 to 3478 | 518 to 1 | 518/518 (100 %) | 0 diff (100 %id) | |||
| BF056981 | pooled germ cell tumors | .f-u | 2963 to 3475 | 513 to 1 | 513/513 (100 %) | 0 diff (100 %id) | |||
| BE673053 | pooled germ cell tumors | .f-u | 2972 to 3475 | 504 to 1 | 504/504 (100 %) | 0 diff (100 %id) | |||
| BQ216517 | melanotic melanoma, skin | .f-u | 2977 to 3475 | 54 to 553 | AAA | 500/553 (90 %) | 6 diff (99.0 %id) | ||
| AI521686 | Kidney | .f-u | 3015 to 3186 | 172 to 1 | 172/172 (100 %) | 2 diff (98.9 %id) | |||
| AI332945 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .f-u | 3016 to 3479 | 469 to 6 | tiling clone, | 464/469 (98 %) | 0 diff (100 %id) | ||
| AI800241 | Kidney | .f-u | 3016 to 3475 | 460 to 1 | 460/460 (100 %) | 0 diff (100 %id) | |||
| H96656 | melanocyte | .f-u | 3020 to 3475 | 458 to 1 | 458/458 (100 %) | 3 diff (99.4 %id) | |||
| AI291313 | placenta | .f-u | 3021 to 3479 | 459 to 1 | 459/459 (100 %) | 1 diff (99.8 %id) | |||
| H88601 | cochlea, ear | .f-u | 3024 to 3450 | 434 to 1 | fully sequenced, | 434/434 (100 %) | 14 diff (96.8 %id) | ||
| AI369449 | anaplastic oligodendroglioma, brain | .f-u | 3029 to 3475 | 447 to 1 | 447/447 (100 %) | 0 diff (100 %id) | |||
| AI085768 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .f-u | 3038 to 3477 | 440 to 1 | 440/440 (100 %) | 0 diff (100 %id) | |||
| N62596 | multiple sclerosis lesions | .f-u | 3047 to 3475 | 436 to 1 | fully sequenced, | 436/436 (100 %) | 7 diff (98.4 %id) | ||
| BE206653 | adenocarcinoma cell line, ovary | .f-u | 3047 to 3475 | 441 to 13 | AAA | 429/429 (100 %) | 6 diff (98.7 %id) | ||
| AA136884 | uterus | .f-u | 3049 to 3485 | 438 to 2 | fully sequenced, | 437/438 (99 %) | 0 diff (100 %id) | ||
| AW051849 | pooled | .f-u | 3056 to 3472 | 417 to 1 | 417/417 (100 %) | 5 diff (98.9 %id) | |||
| BM670701 | eye, fetal eyes | .f-u | 3059 to 3475 | 432 to 16 | AAA | 417/417 (100 %) | 0 diff (100 %id) | ||
| BQ188562 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .f-u | 3085 to 3475 | 1 to 391 | fully sequenced, AAA | 391/391 (100 %) | 0 diff (100 %id) | ||
| TI_151732035 | .f-u | 3085 to 3475 | 468 to 78 | AAA | 391/970 (40 %) | 0 diff (100 %id) | |||
| AW628529 | pooled | .f-u | 3102 to 3475 | 389 to 16 | AAA | 374/374 (100 %) | 1 diff (99.8 %id) | ||
| CN285613 | embryonic stem cells, cell lines H1, H7, andH9 | .f-u | 3103 to 3478 | 1 to 376 | 376/376 (100 %) | 2 diff (99.5 %id) | |||
| AA827843 | germinal center B cell | .f-u | 3109 to 3472 | 389 to 27 | AAA | 363/370 (98 %) | 2 diff (99.5 %id) | ||
| AI025951 | parathyroid gland, parathyroid tumor | .f-u | 3112 to 3479 | 372 to 5 | 368/372 (98 %) | 0 diff (100 %id) | |||
| AA454100 | .f-u | 3114 to 3409 | 1 to 296 | Submitted on the opposite strand | 296/296 (100 %) | 0 diff (100 %id) | |||
| AA961618 | pooled | .f-u | 3117 to 3472 | 356 to 1 | 356/356 (100 %) | 0 diff (100 %id) | |||
| BU533100 | mixed (pool of 40 RNAs) | .f-u | 3132 to 3482 | 1 to 351 | 351/373 (94 %) | 7 diff (98.2 %id) | |||
| CB140386 | Liver | .f-u | 3133 to 3411 | 1 to 279 | 279/279 (100 %) | 0 diff (100 %id) | |||
| H44386 | breast | .f-u | 3138 to 3467 | 1 to 331 | 331/331 (100 %) | 1 diff (99.7 %id) | |||
| AI000264 | Kidney | .f-u | 3141 to 3351 | 211 to 1 | 211/211 (100 %) | 1 diff (99.6 %id) | |||
| AW078937 | 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney | .f-u | 3150 to 3475 | 325 to 1 | 325/325 (100 %) | 1 diff (99.7 %id) | |||
| AW168575 | bowel (skin primary), metastatic melanoma to bowel | .f-u | 3150 to 3479 | 331 to 2 | 330/331 (99 %) | 0 diff (100 %id) | |||
| AW439344 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .f-u | 3150 to 3476 | 327 to 1 | 327/327 (100 %) | 0 diff (100 %id) | |||
| AW339047 | adenocarcinoma, Pancreas | .f-u | 3150 to 3475 | 326 to 1 | 326/326 (100 %) | 0 diff (100 %id) | |||
| AW769001 | colon, moderately-differentiated adenocarcinoma | .f-u | 3150 to 3473 | 324 to 1 | 324/324 (100 %) | 0 diff (100 %id) | |||
| AI094105 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .f-u | 3157 to 3475 | 319 to 1 | 319/319 (100 %) | 0 diff (100 %id) | |||
| AA452517 | .f-u | 3160 to 3468 | 309 to 1 | Submitted on the opposite strand | 309/309 (100 %) | 0 diff (100 %id) | |||
| AA749230 | germinal center B cell | .f-u | 3173 to 3475 | 339 to 37 | AAA | 303/303 (100 %) | 0 diff (100 %id) | ||
| BM452320 | eye, retinoblastoma | .f-u | 3182 to 3468 | 1 to 287 | AAA | 287/287 (100 %) | 0 diff (100 %id) | ||
| AI584078 | adenocarcinoma, Pancreas | .f-u | 3185 to 3475 | 311 to 21 | AAA | 291/291 (100 %) | 4 diff (98.7 %id) | ||
| BI092350 | cervix | .f-u | 3185 to 3481 | 1 to 296 | AAA | 296/296 (100 %) | 3 diff (99.0 %id) | ||
| FN106091 | breast carcinoma | .f-u | 3248 to 3320 | 1 to 72 | 72/73 (98 %) | 2 diff (97.3 %id) | |||
| CK299785 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .f-u | 3265 to 3475 | 226 to 16 | fully sequenced, AAA | 211/211 (100 %) | 0 diff (100 %id) | ||
| EH352504 | .f-u | 3390 to 3485 | 1 to 96 | 96/112 (85 %) | 4 diff (96.5 %id) | ||||
| AA748756 | germinal center B cell | .f-u | 3407 to 3475 | 79 to 11 | AAA | 69/69 (100 %) | 0 diff (100 %id) | ||
| CD655931 | Embryonic Stem cells | .g-u | 1 to 777 | 7 to 778 | S2L | tiling clone, | 772/812 (95 %) | 17 diff (98.0 %id) | |
| CN259428 | embryonic stem cells, DMSO-treated H9 cellline | .h | 1 to 503 | 1 to 503 | exact | tiling clone, | 503/503 (100 %) | 0 diff (100 %id) | |
| GD154216 | .h | 347 to 429 | 1 to 82 | AAA | 82/82 (100 %) | 3 diff (96.4 %id) | |||
| BF431027 | Kidney | .i | 1 to 304 | 304 to 1 | N6K | tiling clone, | 304/304 (100 %) | 1 diff (99.7 %id) | |
| U51699 | heart, normal gingiva | Gene QSER1, variant not shown | Suspected internal deletion, this clone was ignored |
| ? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f-u, .g-u, .h, .i | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes DC |